Catheter Precision Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
VTAK$0.15-0.7%Stored close · as of Oct 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Operations
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenue | $96 | $133 | $271 | $314 |
| Cost of revenues | 10 | 6 | 31 | 23 |
| Gross profit | 86 | 127 | 240 | 291 |
| Operating expenses | ||||
| Loss on impairment of goodwill | — | — | — | 60,934 |
| Selling, general and administrative | 2,882 | 2,745 | 8,251 | 14,393 |
| Research and development | 63 | 112 | 181 | 486 |
| Total operating expenses | 2,945 | 2,857 | 8,432 | 75,813 |
| Operating loss | (2,859) | (2,730) | (8,192) | (75,522) |
| Other income (expense), net | ||||
| Interest income | 7 | 87 | 47 | 293 |
| Interest expense | (32) | — | (40) | (18) |
| Other expense, net | (3) | — | (7) | 11 |
| Change in fair value of royalties payable | (1,233) | 716 | (2,823) | 5,333 |
| Total other income (expense), net | (1,261) | 803 | (2,823) | 5,619 |
| Net loss | $(4,120) | $(1,927) | $(11,015) | $(69,903) |
| Deemed dividend - warrant inducement offer | — | — | — | (800) |
| Net loss attributable to common stockholders | $(4,120) | $(1,927) | $(11,015) | $(70,703) |
| Net loss per share attributable to common stockholders, basic and diluted | $(2.01) | $(2.83) | $(9.28) | $(141.96) |
| Weighted average common shares used in computing net loss per share, basic and diluted | 2,050,947 | 680,596 | 1,187,100 | 498,054 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.